Crossmark

Chromatographic analysis of triple cough therapy; bromhexine, guaiafenesin and salbutamol and pharmaceutical impurity: in-silico toxicity profile of drug impurity

Crossref DOI link: https://doi.org/10.1186/s13065-024-01122-5

Published Online: 2024-01-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sharkawi, Marco M. Z. http://orcid.org/0000-0001-8379-6865
Safwat, Mark T. http://orcid.org/0000-0002-8265-9188
Abdelaleem, Eglal A. http://orcid.org/0000-0002-6461-2490
Abdelwahab, Nada S. http://orcid.org/0000-0002-0700-7542
Funding

Funding for this research was provided by:

Beni Suef University
License Information

Text and Data Mining valid from 2024-01-27

Version of Record valid from 2024-01-27
More Information

Article History

Received: 4 November 2023

Accepted: 10 January 2024

First Online: 27 January 2024

Declarations

:

: Not applicable.

: Authors declare that they have no competing of interest.

Document is current

Any future updates will be listed below